Clinical Trials Directory

Trials / Sponsors / McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attent
Attention Deficit Hyperactivity Disorder
Phase 32006-04-01
CompletedA Safety and Effectiveness Study of Methylphenidate HCl Extended-release Tablets in Adults With Attention Defi
Attention Deficit Disorder With Hyperactivity
Phase 32006-04-01
CompletedAn Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cys
Cystic Fibrosis, Steatorrhea
Phase 22005-07-01
CompletedAn Effectiveness and Safety Study Comparing Oxybutynin Chloride Plus FLOMAX (Tamsulosin HCl) and Placebo Plus
Urination Disorders
Phase 32004-05-01
CompletedAn Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets
Metrorrhagia
Phase 22003-11-01
CompletedAn Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents
Attention Deficit Disorder With Hyperactivity
Phase 32002-03-01
CompletedThe Effect of Norgestimate/Ethinyl Estradiol on Bone Density in Pediatric Subjects With Anorexia Nervosa
Osteoporosis
Phase 2—
CompletedAn Effectiveness and Safety Study of ELMIRON (Pentosan Polysulfate Sodium) for the Treatment of Chronic Non-Ba
Prostatitis
Phase 2—
CompletedCommunity-based Study Comparing Extended-release Methylphenidate and Atomoxetine in Children With Attention-de
Attention Deficit Hyperactivity Disorder
Phase 4—
CompletedSafety & Efficacy Study of Benzydamine Oral Rinse for the Treatment of Oral Mucositis (Mouth Sores) Resulting
Stomatitis, Radiation Effects
Phase 3—
CompletedAn Effectiveness and Safety Study of Cyclobenzaprine HCl Alone or in Combination With Ibuprofen for Acute Back
Pain, Spasm
Phase 4—
CompletedAn Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen
Metrorrhagia
Phase 2—